CLINICAL_TRIALS
trial_result
· 2021-01-22
Clinical Trial Update: Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy [Phase 4]
Summary
Phase 4 trial comparing riociguat to PDE-5 inhibitor therapy in pulmonary arterial hypertension has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2021-01-22